Abstract
Effects of chronic intranasal administration of ACTH(4-10) analog Semax (MEHFPGP) on exploratory activity, anxiety level, and depression-like behaviour were studied in white rats. The peptide was injected daily in dose 0.05 mg/kg during 10 or 14 days. It was shown that chronic Semax administration at 1-2 weeks induced anxiolytic and antidepressant effects but did not influenced the exploratory activity in non-stressogenic environment. The Semax effects may be the results of activation of the brain serotoninergic system as well as increased BDNF expression in the rat hippocampus.
Publication types
-
English Abstract
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenocorticotropic Hormone / analogs & derivatives*
-
Adrenocorticotropic Hormone / pharmacology
-
Animals
-
Antidepressive Agents / pharmacology
-
Behavior, Animal / drug effects*
-
Brain-Derived Neurotrophic Factor / biosynthesis*
-
Emotions / drug effects*
-
Gene Expression Regulation / drug effects*
-
Hippocampus / drug effects*
-
Male
-
Neuroprotective Agents / pharmacology*
-
Peptide Fragments / pharmacology*
-
Rats
Substances
-
Antidepressive Agents
-
Brain-Derived Neurotrophic Factor
-
Neuroprotective Agents
-
Peptide Fragments
-
ACTH (4-7), Pro-Gly-Pro-
-
Adrenocorticotropic Hormone